Analysis of distinct <i>SF3B1</i> hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia
Vera Ademà(Cleveland Clinic), Hetty E. Carraway(Cleveland Clinic), Yasunobu Nagata(Kyoto University), Valeria Visconte(Cleveland Clinic), Jennifer S. Carew(University of Arizona), Aaron T. Gerds(Cleveland Clinic), Yogen Saunthararajah(Cleveland Clinic), Mikkael A. Sekeres(University of Miami), Teodora Kuzmanovic(Cleveland Clinic), Steffan T. Nawrocki(University of Arizona), Heesun J. Rogers(Cleveland Clinic), Cassandra M Kerr(Cleveland Clinic), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Anjali S. Advani(Cleveland Clinic), Jaroslaw P. Maciejewski(Cleveland Clinic), Aziz Nazha, Ying Ni(Beijing Normal University), Yazan F. Madanat(The University of Texas Southwestern Medical Center), Sudipto Mukherjee(Cleveland Clinic), Jack Khouri(Cleveland Clinic), Bhumika J. Patel(Cleveland Clinic), Hassan Awada(Cleveland Clinic)
Cited by 7
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782